Literature DB >> 6109169

Naloxone in shock.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109169

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Increasing incidence of coeliac disease in Sweden.

Authors:  H Ascher; I Krantz; B Kristiansson
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

2.  Rise and fall of coeliac disease 1960-85.

Authors:  D A Kelly; A D Phillips; E J Elliott; J A Dias; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

Review 3.  New developments in the treatment of gram-negative bacteremia.

Authors:  M A Jacobson; L S Young
Journal:  West J Med       Date:  1986-02

4.  Mechanism of action of antipruritic drugs.

Authors:  L Krause; S Shuster
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

5.  Changing infant feeding practices and declining incidence of coeliac disease in West Somerset.

Authors:  D N Challacombe; I K Mecrow; K Elliott; F J Clarke; E E Wheeler
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

6.  The incidence of coeliac disease and early weaning.

Authors:  D N Challacombe
Journal:  Arch Dis Child       Date:  1983-05       Impact factor: 3.791

7.  Different features of coeliac disease in two neighbouring countries.

Authors:  H Ascher; K Holm; B Kristiansson; M Mäki
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

8.  Use of naloxone in septic shock.

Authors:  J Canady; W Williams; I Thompson; G S Vincent; E Hoover
Journal:  J Natl Med Assoc       Date:  1989-06       Impact factor: 1.798

9.  Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia.

Authors:  K G Oldroyd; K Harvey; C E Gray; G H Beastall; S M Cobbe
Journal:  Br Heart J       Date:  1992-03

10.  Naloxone in septic shock: report of two cases.

Authors:  S Siram; S Y Park
Journal:  J Natl Med Assoc       Date:  1984-07       Impact factor: 1.798

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.